ICL
Icl Group Ltd
NYSE · Chemicals
$5.49
+0.07 (+1.29%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 21.21B | 21.32B | 6.86B | 7.12B | 6.72B |
| Net Income | 1.26B | 1.14B | 907.81M | 1.28B | 1.02B |
| EPS | — | — | — | — | — |
| Profit Margin | 6.0% | 5.7% | 13.2% | 18.0% | 15.1% |
| Rev Growth | -0.6% | -0.6% | +12.1% | +21.5% | +18.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 3.14B | 3.14B | 3.48B | 3.42B | 3.02B |
| Total Equity | 7.84B | 7.84B | 11.56B | 10.49B | 11.64B |
| D/E Ratio | 0.40 | 0.40 | 0.30 | 0.33 | 0.26 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 4.19B | 4.00B | 1.89B | 1.79B | 1.80B |
| Free Cash Flow | — | — | 722.26M | 781.09M | 495.76M |